ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,618.26
      -0.29%
      US Tech 100
      19,242.00
      2.04%
      Dow Jones
      41,503.10
      -0.25%
      Brent Oil
      73.825
      2.00%
      Bitcoin
      62,510.73
      1.36%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Mesoblast Limited (MESO) Quote

      Mesoblast Limited

      Mesoblast Limited (MESO)

      NASDAQ
      6.19
      0.09
      (1.48%)
      Closed September 18 4:00PM
      Delayed by 15 minutes
      6.26
      0.07
      ( 1.13% )
      Pre Market: 7:00AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      6.26
      Bid
      6.25
      Ask
      6.62
      Volume
      100
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      714.757M
      Previous Close
      6.19
      Open
      -
      Last Trade
      100
      @
      6.26
      (formt)
      Last Trade Time
      07:00:00
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      114,178,411
      Dividend Yield
      -
      PE Ratio
      -1.25
      Earnings Per Share (EPS)
      -0.77
      Revenue
      9.25M
      Net Profit
      -87.96M

      About Mesoblast Limited

      Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-... Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.mesoblast.com
      Headquarters
      Melbourne, Victoria, Aus
      Founded
      -
      Mesoblast Limited is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MESO. The last closing price for Mesoblast was $6.19. Over the last year, Mesoblast shares have traded in a share price range of $ 0.00 to $ 0.00.

      Mesoblast currently has 114,178,411 shares outstanding. The market capitalization of Mesoblast is $706.76 million. Mesoblast has a price to earnings ratio (PE ratio) of -1.25.

      Ask ADVFN Intelligence (AI)

      MESO Latest News

      More News

      FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

      21 hours ago

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      August 29 2024
      Edgar (US Regulatory)

      Mesoblast Reports Financial Results and Operational Update for Fiscal Year Ended June 30, 2024

      NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an operational...

      August 28 2024
      GlobeNewswire Inc.

      Mesoblast Financial Results and Corporate Update Webcast

      NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss...

      August 27 2024
      GlobeNewswire Inc.

      Appendix 4C Quarterly Activity Report for Quarter Ended June 30, 2024

      NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its...

      July 30 2024
      GlobeNewswire Inc.

      FDA Accepts Mesoblast’s Biologics License Application (BLA) for Ryoncil® in Children With Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)

      NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the United States...

      July 23 2024
      GlobeNewswire Inc.

      Patient Enrollment Commenced in Pivotal Phase 3 Trial of Rexlemestrocel-L for Chronic Low Back Pain

      NEW YORK, July 21, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today that the...

      July 21 2024
      GlobeNewswire Inc.

      Mesoblast Resubmits Biologics License Application (BLA) with United States Food & Drug Administration (FDA) for Approval of Ryoncil® in Children with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)

      NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today it has resubmitted...

      July 08 2024
      GlobeNewswire Inc.

      Mesoblast to File Biologics License Application for Ryoncil® FDA Approval Next Week

      NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today confirmed that it will file...

      July 01 2024
      GlobeNewswire Inc.

      Mesoblast Corporate Presentation at Investor Conference

      NEW YORK, June 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), Chief Executive Silviu Itescu provided a corporate update at the Bell Potter Emerging Leaders Conference...

      June 02 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TBIOTelesis Bio Inc
      $ 4.74
      (248.53%)
      		8.57M
      ZEOZeo Energy Corporation
      $ 3.62
      (217.54%)
      		3.94M
      XCURExicure Inc
      $ 5.91
      (158.08%)
      		3.61M
      VEROVenus Concept Inc
      $ 0.906
      (80.30%)
      		3.67M
      FRGTFreight Technologies Inc
      $ 0.1619
      (30.67%)
      		27.42M
      PGNYProgyny Inc
      $ 18.02
      (-26.27%)
      		87.23k
      VVOSVivos Therapeutics Inc
      $ 3.26
      (-21.07%)
      		274.26k
      ATMCAlphaTime Acquisition Corporation
      $ 9.00
      (-19.64%)
      		10
      HPAIHelport AI Ltd
      $ 4.78
      (-18.98%)
      		64
      CUTRCutera Inc
      $ 0.64
      (-16.05%)
      		13
      FRGTFreight Technologies Inc
      $ 0.1619
      (30.67%)
      		27.42M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.103
      (13.31%)
      		15.09M
      TBIOTelesis Bio Inc
      $ 4.74
      (248.53%)
      		8.57M
      VMARVision Marine Technologies Inc
      $ 0.6899
      (14.41%)
      		5.08M
      SQQQProShares UltraPro Short QQQ
      $ 7.90
      (-5.95%)
      		4.19M

      MESO Discussion

      View Posts
      Monksdream Monksdream 2 weeks ago
      MESO under $7
      👍️0
      Monksdream Monksdream 2 months ago
      MESO under $8
      👍️0
      Monksdream Monksdream 5 months ago
      MESO like the chart
      👍️0
      gail gail 6 months ago
      and she dipped, watching for re entry maybe.
      👍️0
      gail gail 6 months ago
      boom, off she runs even more. wow!
      👍️0
      gail gail 6 months ago
      about to bust the HOD here.
      👍️0
      gail gail 6 months ago
      and there she goes. off to the races.
      👍️0
      gail gail 6 months ago
      quiet board, loving this run so far!
      👍️0
      gail gail 6 months ago
      here we gooooo!!! weeee!!!
      👍️0
      gail gail 6 months ago
      grabbed some here.
      👍️0
      Awl416 Awl416 6 months ago
      ….
      👍️0
      Awl416 Awl416 6 months ago
      Continues…..
      👍️0
      stressfreeliving stressfreeliving 6 months ago
      Picked up shares. Look forward to where this goes.

      $MESO
      👍️0
      Invest-in-America Invest-in-America 6 months ago
      MESO: And the hands-down WINNER of the day is MESO!!!!
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      MESO out
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      MESO shake over and ready to go
      👍️0
      TrendTrade2016 TrendTrade2016 6 months ago
      MESO...MONSTER COMING IN HERE
      👍️0
      Monksdream Monksdream 7 months ago
      MESO under $2
      👍️0
      powerbattles powerbattles 7 months ago
      I can't believe stock doesn't move on this great news.
      👍️0
      Awl416 Awl416 8 months ago
      United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease
      👍️0
      Monksdream Monksdream 8 months ago
      MESO new 52 week low
      👍️0
      TheFinalCD TheFinalCD 9 months ago
      where have I heard that before?
      👍️0
      Monksdream Monksdream 9 months ago
      A rising tide lifts all boats, including the leaking ones
      👎️ 1
      TheFinalCD TheFinalCD 9 months ago
      https://www.mesoblast.com/
      👍️0
      Monksdream Monksdream 12 months ago
      MESO under $2
      👍️0
      abrasivegritin abrasivegritin 1 year ago
      I think COmpany should have a look at new markets specially in Russia Ukraine , since all the things there are been destroyed and revaming them need Sand blasting and Shot blasting service . with all kind of Abrasive like Silicon Carbide and Aluminum Oxide Grit
      👍️0
      basssque basssque 2 years ago
      5 day chart looks good, I'm in!
      👍️0
      Docstemcell2020 Docstemcell2020 3 years ago
      How you doing
      👍️0
      Docstemcell2020 Docstemcell2020 3 years ago
      Let's go Brando
      👍️0
      REAGAN REAGAN 3 years ago
      All of these RegMed stocks are scams bullshit 2000’s era stocks that never came to fruition.
      👍️0
      Docstemcell2020 Docstemcell2020 3 years ago
      No
      👍️0
      midastouch017 midastouch017 3 years ago
      Wasn't PSTI not $13 not too long ago?
      👍️0
      Docstemcell2020 Docstemcell2020 3 years ago
      Wasn't this $17 not too long ago.
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      What's the frequency Dan
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      Lol
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      Yes
      👍️0
      midastouch017 midastouch017 4 years ago
      Lol, are you absolutely sure?
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      This one's going down under
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      See post #232 FangFang sold over 2 million shares yesterday.
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      WOW!
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      Holy Moly
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      Halted until Friday
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      Plausible deniability
      👍️0
      trickledownfacists trickledownfacists 4 years ago
      Nice work!
      👍️0
      Glider549 Glider549 4 years ago
      https://biopharmcatalyst.us13.list-manage.com/track/click?u=ce642b003b32103d28995373d&id=26ab819ef9&e=d1924831d6
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      Down over 50%
      👍️0
      creationtruth creationtruth 4 years ago
      News out tomorrow for CYDY Tomorrow 4ET. Hopefully we’ll get treated better than MESO.
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      This is Getting ugly
      👍️0
      emit emit 4 years ago
      I let go 1/3 my psti this morning.

      Sold all this to.


      e
      👍️0
      Docstemcell2020 Docstemcell2020 4 years ago
      PSTI
      👍️0

      Your Recent History

      NASDAQ
      MESO
      Mesoblast
      Delayed Upgrade Clock